Target intelligence / Profile preview

EML2 antisense RNA 1 (EML2-AS1)

Target
EML2-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

EML2 antisense RNA 1 (EML2-AS1), also known as C19orf83, is a long non-coding RNA (lncRNA) gene located on chromosome 19[1][5]. EML2-AS1 is classified as an antisense RNA because it is transcribed from the opposite genomic strand of the EML2 gene[8]. This lncRNA has been implicated in cellular processes such as proliferation, migration, and apoptosis, and its expression is often altered in various cancer types[2]. However, EML2-AS1 itself is not a therapeutic target like a receptor, enzyme, or transporter, and there are currently no known drugs or biomarkers associated with it. Its main recognized relevance is its potential role in cancer biology as a lncRNA influencing cellular behavior through regulation of gene expression[2][5].

Other names
C19orf83
02

Biological functions

Regulation of cell proliferationRegulation of cell migrationRegulation of apoptosis
03

Disease associations

Cancer

Beyond the preview

Go deeper on EML2 antisense RNA 1 (EML2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EML2 antisense RNA 1 (EML2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call